Regis Healthcare (ASX:REG) - Managing Director and CEO, Linda Mellors
Managing Director and CEO, Linda Mellors
Source: Regis Healthcare
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Aged care provider Regis (REG) has found probable underpayments of up to $40 million over the course of six years
  • Some employee entitlements payable under multiple enterprise agreements were incorrectly entered in the payroll system
  • While the investigation is ongoing, Regis thinks that possible underpayments may be in the region of $30-$40 million
  • Regis has made a voluntary disclosure to the Fair Work Ombudsman
  • Shares in Regis have tumbled 8.10 per cent, trading at $1.93 at 1:03 pm AEST

Aged care provider Regis (REG) has told investors that it has uncovered underpayments to staff of up to $60 million over six years because employee entitlements were recorded inaccurately in its payroll system.

Regis has begun an investigation with the help of external consultants to assess the extent of the underpayments.

While the investigation is ongoing, Regis thinks that possible underpayments to current and past workers (looking back six years) might be in the region of $30-$40 million based on early research.

Regis has stated it will not attempt to recoup any overpayments made in error to workers.

Regis managing director and CEO Linda Mellors said while the company was deeply disappointed the underpayments had occurred, its priority is to identify the amounts owed.

“We are also upgrading our payroll system and improving internal processes to mitigate the risk of such issues recurring,” Dr Mellors said.

“Our board is meeting regularly to monitor progress and ensure remediation occurs in a timely manner. I would like to offer my apologies to our people affected by this issue.”

The expected range of underpayments is expected to have a $6-$7 million impact on profit before income tax for the financial year ended 30 June 2021.

The remaining amount will be recorded as a prior period restatement in accordance with Australian Accounting Standard AASB 108. 

Regis said its capacity to satisfy debt covenants remained unaffected.

The ongoing financial effect of the employee entitlement underpayments is expected to be reduced in the 2022 financial year, according to Regis. This is due to the measures under way to modernise the payroll system and enhance internal processes.

Regis has made a voluntary disclosure to the Fair Work Ombudsman (FWO) and said it would continue to communicate with workers and the FWO as the investigation progressed.

Shares in Regis tumbled 8.10 per cent, trading at $1.93 at 1:03 pm AEST.

REG by the numbers
More From The Market Online
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…